These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10854148)

  • 1. Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer.
    Hassan W; Sanford MA; Woo SL; Chen SH; Hall SJ
    World J Urol; 2000 Apr; 18(2):130-5. PubMed ID: 10854148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
    Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
    BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer.
    Hall SJ; Mutchnik SE; Chen SH; Woo SL; Thompson TC
    Int J Cancer; 1997 Jan; 70(2):183-7. PubMed ID: 9009158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
    Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC
    Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
    Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
    Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
    Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
    Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer.
    Atkinson G; Hall SJ
    Urology; 1999 Dec; 54(6):1098-104. PubMed ID: 10604717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.
    Kubo H; Gardner TA; Wada Y; Koeneman KS; Gotoh A; Yang L; Kao C; Lim SD; Amin MB; Yang H; Black ME; Matsubara S; Nakagawa M; Gillenwater JY; Zhau HE; Chung LW
    Hum Gene Ther; 2003 Feb; 14(3):227-41. PubMed ID: 12639303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy.
    Boucher PD; Im MM; Freytag SO; Shewach DS
    Cancer Res; 2006 Mar; 66(6):3230-7. PubMed ID: 16540675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.
    Nasu Y; Bangma CH; Hull GW; Yang G; Wang J; Shimura S; McCurdy MA; Ebara S; Lee HM; Timme TL; Thompson TC
    Prostate Cancer Prostatic Dis; 2001; 4(1):44-55. PubMed ID: 12497062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
    Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
    Wildner O; Blaese RM; Morris JC
    Cancer Res; 1999 Jan; 59(2):410-3. PubMed ID: 9927055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy.
    Nasu Y; Saika T; Ebara S; Kusaka N; Kaku H; Abarzua F; Manabe D; Thompson TC; Kumon H
    Mol Ther; 2007 Apr; 15(4):834-40. PubMed ID: 17327829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor effect of herpes simplex virus thymidine kinase gene therapy in rat hepatocellular carcinoma: feasibility of adenovirus-mediated intra-arterial gene delivery.
    Kwon HC; Kim JH; Kim KC; Lee KH; Lee JH; Lee BH; Lee KH; Jang JJ; Lee CT; Lee H; Kim CM
    Mol Cells; 2001 Apr; 11(2):170-8. PubMed ID: 11355697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.